1 July 2023 v2025.18.1 limited_company_frs_102_section_1a_v1_1_2 companies_houseSoftwarefalsetruetruetrueNo description of principal activityfalsetruexbrli:purexbrli:sharesiso4217:GBP072771102023-07-012024-06-30072771102024-06-30072771102023-06-3007277110core:WithinOneYear2024-06-3007277110core:WithinOneYear2023-06-3007277110core:AfterOneYear2024-06-3007277110core:AfterOneYear2023-06-3007277110core:ShareCapital2024-06-3007277110core:ShareCapital2023-06-3007277110core:RetainedEarningsAccumulatedLosses2024-06-3007277110core:RetainedEarningsAccumulatedLosses2023-06-3007277110bus:Director12023-07-012024-06-3007277110bus:RegisteredOffice2023-07-012024-06-3007277110core:NetGoodwill2023-07-012024-06-3007277110core:OfficeEquipment2023-07-012024-06-3007277110core:FurnitureFittings2023-07-012024-06-30072771102022-07-012023-06-3007277110core:NetGoodwill2024-06-3007277110core:NetGoodwill2023-06-3007277110core:PlantMachinery2023-07-0107277110core:PlantMachinery2023-07-012024-06-3007277110core:PlantMachinery2024-06-3007277110core:PlantMachinery2023-06-300727711012023-07-012024-06-3007277110countries:EnglandWales2023-07-012024-06-3007277110bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3007277110bus:PrivateLimitedCompanyLtd2023-07-012024-06-3007277110bus:SmallEntities2023-07-012024-06-3007277110bus:FullAccounts2023-07-012024-06-30
Company registration number:
07277110
Mapex Pharmacy Consultancy Limited
Unaudited Filleted Financial Statements for the year ended
30 June 2024
Mapex Pharmacy Consultancy Limited
Report to the board of directors on the preparation of the unaudited statutory financial statements of Mapex Pharmacy Consultancy Limited
Year ended
30 June 2024
As described on the statement of financial position, the Board of Directors of
Mapex Pharmacy Consultancy Limited
are responsible for the preparation of the
financial statements
for the year ended
30 June 2024
, which comprise the income statement, statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006.
In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
Hartmans
11 Mackenzie Road
Moseley
Birmingham
B11 4EP
United Kingdom
Mapex Pharmacy Consultancy Limited
Statement of Financial Position
30 June 2024
20242023
Note££
Fixed assets    
Intangible assets 5
728,686
 
728,686
 
Tangible assets 6
15,841
 
15,626
 
744,527
 
744,312
 
Current assets    
Stocks
52,655
 
37,908
 
Debtors 7
36,599
 
88,216
 
Cash at bank and in hand
74,381
 
41,005
 
163,635
 
167,129
 
Creditors: amounts falling due within one year 8
(237,683
)
(256,213
)
Net current liabilities
(74,048
)
(89,084
)
Total assets less current liabilities 670,479   655,228  
Creditors: amounts falling due after more than one year 9
(568,603
)
(586,267
)
Net assets
101,876
 
68,961
 
Capital and reserves    
Called up share capital
5
 
5
 
Profit and loss account
101,871
 
68,956
 
Shareholders funds
101,876
 
68,961
 
For the year ending
30 June 2024
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
27 March 2025
, and are signed on behalf of the board by:
Mr G Matharu
Director
Company registration number:
07277110
Mapex Pharmacy Consultancy Limited
Notes to the Financial Statements
Year ended
30 June 2024

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
1st Floor Office C/O Westchem Pharmacy
,
89 Station Road
,
West Wickham
,
Kent
,
BR4 0PX
, England.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Goodwill

Purchased goodwill arises on business acquisitions and represents the difference between the cost of acquisition and the fair values of the identifiable assets and liabilities acquired.
Goodwill is initially recorded at cost, and is subsequently stated at cost less any accumulated amortisation and accumulated impairment losses if any. It is then amortised on a straight-line basis over the useful economic life of the asset.

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.
Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Office equipment
10% Reducing balance
Fixtures and fittings
25% Reducing balance

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Defined contribution pension plan

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.

4 Average number of employees

The average number of persons employed by the company during the year was
9
(2023:
9.00
).

5 Intangible assets

Goodwill
£
Cost  
At
1 July 2023
and
30 June 2024
728,686
 
Amortisation  
At
1 July 2023
and
30 June 2024
-  
Carrying amount  
At
30 June 2024
728,686
 
At 30 June 2023
728,686
 

6 Tangible assets

Plant and machinery etc.
£
Cost  
At
1 July 2023
21,951
 
Additions
2,912
 
At
30 June 2024
24,863
 
Depreciation  
At
1 July 2023
6,325
 
Charge
2,697
 
At
30 June 2024
9,022
 
Carrying amount  
At
30 June 2024
15,841
 
At 30 June 2023
15,626
 

7 Debtors

20242023
££
Trade debtors
18,965
 
68,372
 
Other debtors
17,634
 
19,844
 
36,599
 
88,216
 

8 Creditors: amounts falling due within one year

20242023
££
Trade creditors
121,101
 
132,262
 
Taxation and social security
9,755
 
1,136
 
Other creditors
106,827
 
122,815
 
237,683
 
256,213
 

9 Creditors: amounts falling due after more than one year

20242023
££
Bank loans and overdrafts
568,603
 
586,267
 

10 Director's advances, credit and guarantees

At the period end the amount advanced by the director included within other creditors was £98.835 (2023:£105,814). This amount that is made up of numerous transactions was the maximum owed to the director during the period.